NYMOX PHARMACEUTICAL CORP (NYMXF) research
NYMOX PHARMACEUTICAL CORP- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.00
- As of
Share the NYMXF intelligence card
See NYMXF live in the terminal
Track NYMXF's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live NYMXF terminal, freeActive signals for NYMXF
- mediumEARNINGS_BEAT
Q3-2013: Beat consensus by 43.5% - EPS $-0.03 vs $-0.0531 estimate
- mediumEARNINGS_BEAT
Q4-2013: Beat consensus by 43.5% - EPS $-0.03 vs $-0.0531 estimate
- mediumEARNINGS_BEAT
Q4-2013: Beat consensus by 24.7% - EPS $-0.04 vs $-0.0531 estimate
FREE, NO ACCOUNT
Every signal on NYMXF, as it fires
New filings, 13F moves and cross asset signals on NYMXF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, NYMXF
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Related tickers
See more NYMXF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NYMXFand get the insider, 13F, options, and confluence read in one view.